These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9568870)

  • 21. The effects of macrolide and quinolone antibiotics in methicillin-resistant Staphylococcus aureus biofilm growth.
    Dasgupta MK; Shishido H; Salama S; Singh R; Larabie M; Micetich RG
    Adv Perit Dial; 1997; 13():214-7. PubMed ID: 9360684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of disk diffusion and agar dilution methods for erythromycin and ciprofloxacin susceptibility testing of Campylobacter jejuni subsp. jejuni.
    Gaudreau C; Girouard Y; Ringuette L; Tsimiklis C
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1524-6. PubMed ID: 17261628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic susceptibility patterns of Neisseria gonorrhoeae isolates in Port Elizabeth.
    Govender S; Lebani T; Nell R
    S Afr Med J; 2006 Mar; 96(3):225-6. PubMed ID: 16607434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between pefloxacin and aminophylline in genetically epilepsy-prone rats.
    Imperatore C; Trimarchi GR; De Sarro A
    J Pharm Pharmacol; 1997 Oct; 49(10):1025-9. PubMed ID: 9364414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria.
    Sefton AM; Maskell JP; Rafay AM; Whiley A; Williams JD
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():57-62. PubMed ID: 9222071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method].
    Žemličková H; Jakubů V; Marejková M; Urbášková P
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
    Gevaudan MJ; Bollet C; Mallet MN; de Micco P
    Pathol Biol (Paris); 1991 May; 39(5):436-41. PubMed ID: 1652732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
    Barker JE; Farrell ID
    J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rectal microscopy in men - expensive, time consuming and inappropriate.
    Waters L; Worthen E; O'mahony C
    Int J STD AIDS; 2006 Oct; 17(10):710. PubMed ID: 17059644
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline.
    Hamilton RA; Gordon T
    Ann Pharmacother; 1992 Dec; 26(12):1507-11. PubMed ID: 1482803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
    Azoulay-Dupuis E; Bedos JP; Vallée E; Hardy DJ; Swanson RN; Pocidalo JJ
    J Infect Dis; 1991 Feb; 163(2):319-24. PubMed ID: 1988515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of moxifloxacin compared to other fluoroquinolones against different erythromycin-resistant phenotypes of group A beta-hemolytic streptococcus.
    Esposito S; Noviello S; Ianniello F; Novelli A
    Chemotherapy; 2000; 46(1):23-7. PubMed ID: 10601794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of thiamphenicol, erythromycin and fluoroquinolones against Legionella pneumophila.
    Bonfiglio G; Lanzafame A; Santini L; Mattina R
    J Chemother; 2004 Oct; 16(5):502-3. PubMed ID: 15565921
    [No Abstract]   [Full Text] [Related]  

  • 37. Ciprofloxacin-phenytoin interaction.
    Brouwers PJ; de Boer LE; Guchelaar HJ
    Ann Pharmacother; 1997 Apr; 31(4):498. PubMed ID: 9101016
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
    Ismaeel NA
    Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodamage to multidrug-resistant gram-positive and gram-negative bacteria by 870 nm/930 nm light potentiates erythromycin, tetracycline and ciprofloxacin.
    Bornstein E; Gridley S; Wengender P; Robbins A
    Photochem Photobiol; 2010; 86(3):617-27. PubMed ID: 20408973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
    Rodríguez-Avial I; Rodríguez-Avial C; Picazo JJ
    Rev Esp Quimioter; 2001 Dec; 14(4):364-8. PubMed ID: 11856983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.